Evolving Treatments of Metastatic CRC: Insights from ASCO 2024 - Episode 5

Existing Challenges for Patients Receiving 3L+ Therapies in mCRC

, , , ,

The colorectal cancer experts offer insights on a patient case and investigate the obstacles faced by patients with metastatic colorectal cancer requiring third-line or later therapy.

  1. Dr Marshall to Panel: Briefly provide comments and perspectives on this patient case.
  2. Dr Marshall to Dr Ciombor: What present challenges exist for patients with mCRC requiring 3L+ therapy?
    • With evolving data and latest approvals, have we gotten closer to addressing those challenges and if so, how?